PNC Financial Services Group’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105 Hold
128
﹤0.01% 5143
2026
Q1
$118 Hold
128
﹤0.01% 5086
2025
Q4
$164 Hold
128
﹤0.01% 5000
2025
Q3
$166 Hold
128
﹤0.01% 4956
2025
Q2
$154 Hold
128
﹤0.01% 4815
2025
Q1
$138 Hold
128
﹤0.01% 4802
2024
Q4
$224 Hold
128
﹤0.01% 4641
2024
Q3
$247 Hold
128
﹤0.01% 4657
2024
Q2
$227 Hold
128
﹤0.01% 4648
2024
Q1
$347 Sell
128
-9
-7% -$22 ﹤0.01% 4536
2023
Q4
$303 Buy
+137
New +$292 ﹤0.01% 4457
2021
Q1
Sell
-1,000
Closed -$6K 4160
2020
Q4
$6K Hold
1,000
﹤0.01% 3680
2020
Q3
$7K Buy
+1,000
New +$6.9K ﹤0.01% 3601
2017
Q2
Sell
-70
Closed 4192
2017
Q1
$0 Hold
70
﹤0.01% 4159
2016
Q4
$1K Sell
70
-1,021
-94% -$6.41K ﹤0.01% 3925
2016
Q3
$9K Sell
1,091
-184
-14% -$1.69K ﹤0.01% 3511
2016
Q2
$12K Sell
1,275
-7
-0.5% -$66 ﹤0.01% 3467
2016
Q1
$11K Buy
1,282
+1,060
+477% +$7.64K ﹤0.01% 3532
2015
Q4
$2K Hold
222
﹤0.01% 4171
2015
Q3
$1K Sell
222
-187
-46% -$2.94K ﹤0.01% 4470
2015
Q2
$10K Buy
409
+81
+25% +$2.56K ﹤0.01% 3794
2015
Q1
$14K Buy
328
+13
+4% +$514 ﹤0.01% 3653
2014
Q4
$11K Hold
315
﹤0.01% 3348
2014
Q3
$8K Hold
315
﹤0.01% 3332
2014
Q2
$9K Hold
315
﹤0.01% 3155
2014
Q1
$14K Buy
315
+84
+36% +$3.7K ﹤0.01% 2964
2013
Q4
$9K Hold
231
﹤0.01% 3014
2013
Q3
$5K Hold
231
﹤0.01% 3407
2013
Q2
$4K Buy
+231
New +$4.05K ﹤0.01% 3312

Other funds holding LAB

PNC Financial Services Group's LAB Position: Q2 2026 in Review

PNC Financial Services Group held its Standard BioTools (LAB) position steady in Q2 2026 at 128 shares worth $105. The position accounts for ﹤0.01% of the portfolio, ranked #5143.

PNC Financial Services Group first reported a position in LAB in Q2 2013 and has held it in 29 quarters since. The position peaked at $14K in Q1 2015. 40 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • PNC Financial Services Group held 128 shares of Standard BioTools worth $105 as of Q2 2026.
  • PNC Financial Services Group left its Standard BioTools share count unchanged in Q2 2026.
  • Standard BioTools made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5143 holding.
  • PNC Financial Services Group first reported a position in Standard BioTools in Q2 2013 and has held it in 29 quarters since.
  • PNC Financial Services Group's Standard BioTools position peaked at $14K in Q1 2015.
  • 40 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.